5592 J ournal of Medicinal Chemistry, 2002, Vol. 45, No. 25
Wheelock et al.
(23) Gupta, R. C.; Dettbarn, W. D. Role of carboxylesterases in the
prevention and potentiation of N-methylcarbamate toxicity.
Chem. Biol. Interact. 1993, 87, 295-303.
(49) Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti
correlation-energy formula into a functional of the electron
density. Phys. Rev. B 1988, 37, 785-789.
(50) Schu¨u¨rmann, G.; Cossi, M.; Barone, V.; Tomasi, J . Prediction of
the pKa of carboxylic acids using the ab initio continuum-
solvation model PCM-UAHF. J . Phys. Chem. A 1998, 102, 6706-
6712.
(51) Tran, N. L.; Colvin, M. E. The prediction of biochemical acid
dissociation constants using first principles quantum chemical
simulations. J . Mol. Struct.: THEOCHEM 2000, 532, 127-137.
(52) Barone, V.; Cossi, M. Quantum calculation of molecular energies
and energy gradients in solution by a conductor solvent model.
J . Phys. Chem. 1998, 102, 1995-2001.
(53) Floria´n, J .; Warshel, A. Langevin dipoles model for ab initio
calculations of chemical processes in solution: Parametrization
and application to hydration free energies of neutral and ionic
solutes and conformational analysis in aqueous solution. J . Phys.
Chem. B 1997, 101, 5583-5595.
(54) Luzhkov, V.; Warshel, A. Microscopic models for quantum-
mechanical calculations of chemical processes in solutionssLD/
AMPAC and SCAAS/AMPAC calculations of solvation energies.
J . Comput. Chem. 1992, 13, 199-213.
(55) Reed, A. E.; Weinstock, R. B.; Weinhold, F. Natural population
analysis. J . Chem. Phys. 1985, 83, 735-746.
(56) AMPAC, version 6.55; Semichem Inc.: Kansas City, MO, 1999.
(57) Tolls, J .; van Dijk, J .; Verbruggen, E. J . M.; Hermens, J . L. M.;
Loeprecht, B.; et al. Aqueous solubility-molecular size relation-
ships: A mechanistic case study using C-10- to C-19-alkanes.
J . Phys. Chem. A 2002, 106, 2760-2765.
(58) Hout, R. F., J r.; Levi, B. A.; Hehre, W. J . Effect of electron
correlation on theoretical vibrational frequenies. J . Comput.
Chem. 1982, 3, 234-250.
(59) Frisch, M. J .; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.;
Robb, M. A.; Cheeseman, J . R.; Zakrzewski, V. G.; Montgomery,
J . A., J r.; Stratmann, R. E.; Burant, J . C.; Dapprich, S.; Millam,
J . M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.;
Tomasi, J .; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.;
Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J .; Petersson, G.
A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck,
A. D.; Raghavachari, K.; Foresman, J . B.; Cioslowski, J .; Ortiz,
J . V.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.;
Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J .; Keith, T.;
Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.;
Challacombe, M.; Gill, P. M. W.; J ohnson, B. G.; Chen, W.; Wong,
M. W.; Andres, J . L.; Head-Gordon, M.; Replogle, E. S.; Pople,
J . A. Gaussian 98, revision A.7; Gaussian, Inc.: Pittsburgh, PA,
1998.
(24) Buchwald, P.; Bodor, N. Quantitative structure-metabolism
relationships: Steric and nonsteric effects in the enzymatic
hydrolysis of noncongener carboxylic esters. J . Med. Chem. 1999,
42, 5160-5168.
(25) Bodor, N.; Buchwald, P. Soft drug design: General principles
and recent applications. Med. Res. Rev. 2000, 20, 58-101.
(26) Molinoff, P. B.; Ruddon, R. W. Goodman
& Gilman’s the
pharmacological basis of therapeutics, 9th ed.; Hardman, J . G.,
Limbird, L. E., Eds.; McGraw-Hill: New York, 1996; p 1905.
(27) Quinn, D. M. Esterases of the R/â hydrolase fold family.
Biotransformation; Elsevier Science: Oxford, 1997; pp 243-264.
(28) Quinn, D. M. Ester hydrolysis. Enzymes, Enzyme Mechanisms,
Proteins, and Aspects of NO Chemistry; Elsevier Science: Oxford,
1999; pp 101-137.
(29) Nair, H. K.; Lee, K.; Quinn, D. M. m-(N,N,N-Trimethylammo-
nio)trifluoroacetophenone: A femtomolar inhibitor of acetylcho-
linesterase. J . Am. Chem. Soc. 1993, 115, 9939-9941.
(30) Amour, A.; Reboud-Ravaux, M.; de Rosny, E.; Abouabdellah, A.;
Begue, J . P.; et al. Stereoselective synthesis of peptidyl trifluo-
romethyl alcohols and ketones: Inhibitory potency against
human leucocyte elastase, cathepsin G, porcine pancreatic
elastase and HIV-1 protease. J . Pharm. Pharmacol. 1998, 50,
593-600.
(31) Veale, C. A.; Bernstein, P. R.; Bohnert, C. M.; Brown, F. J .;
Bryant, C.; et al. Orally active trifluoromethyl ketone inhibitors
of human leukocyte elastase. J . Med. Chem. 1997, 40, 3173-
3181.
(32) Edwards, P. D.; Andisik, D. W.; Bryant, C. A.; Ewing, B.; Gomes,
B.; et al. Discovery and biological activity or orally active peptidyl
trifluoromethyl ketone inhibitors of human neutrophil elastase.
J . Med. Chem. 1997, 40, 1876-1885.
(33) Boger, D. L.; Sato, H.; Lerner, A. E.; Austin, B. J .; Patterson, J .
E.; et al. Trifluoromethyl ketone inhibitors of fatty acid amide
hydrolase: A probe of structural and conformational features
contributing to inhibition. Bioorg. Med. Chem. Lett. 1999, 9,
265-270.
(34) Wheelock, C. E.; Severson, T. F.; Hammock, B. D. Synthesis of
new carboxylesterase inhibitors and evaluation of potency and
water solubility. Chem. Res. Toxicol. 2001, 14, 1563-1572.
(35) Sze´ka´cs, A.; Borda´s, B.; Hammock, B. D. Transition state analog
enzyme inhibitors: Structure-activity relationships of trifluo-
romethyl ketones. Rational Approaches to Structure, Activity,
and Ecotoxicology of Agrochemicals; CRC Press: Boca Raton,
FL, 1992; pp 219-249.
(36) Hammock, B. D.; Wing, K. D.; McLaughlin, J .; Lovell, V. M.;
Sparks, T. C. Trifluoromethylketones as possible transition state
analog inhibitors of juvenile hormone esterase. Pestic. Biochem.
Physiol. 1982, 17, 76-88.
(37) Wolfenden, R. Transition state analogues for enzyme catalysis.
Nature 1969, 223, 704-705.
(38) Lienhard, G. E. Enzymatic catalysis and transition-state theory.
Science 1973, 180, 149-154.
(60) Floria´n, J .; Warshel, A. ChemSol, version 2.1; University of
Southern California: Los Angeles, CA, 1998.
(61) Sparks, T.; Hammock, B. Induction and regulation of juvenile
hormone esterases during the last larval instar of the cabbage
looper, Trichoplusia Ni. J . Insect Physiol. 1979, 25, 551-560.
(62) Abdel-Aal, Y. A. I.; Hammock, B. D. Transition state analogs as
ligands for affinity purification of juvenile hormone esterase.
Science 1986, 233, 1073-1075.
(39) Huang, T. L.; Shiotsuki, T.; Uematsu, T.; Borhan, B.; Li, Q. X.;
et al. Structure-activity relationships for substrates and inhibi-
tors of mammalian liver microsomal carboxylesterases. Pharm.
Res. 1996, 13, 1495-1500.
(40) Brodbeck, U.; Schweikert, K.; Gentinetta, R.; Rottenberg, M.
Fluorinated aldehydes and ketones acting as quasi-substrate
inhibitors of acetylcholinesterase. Biochim. Biophys. Acta 1979,
567, 357-369.
(41) Ashour, M. B. A.; Hammock, B. D. Substituted trifluoroketones
as potent, selective inhibitors of mammalian carboxylesterases.
Biochem. Pharmacol. 1987, 36, 1869-1879.
(42) Linderman, R. J .; Upchurch, L.; Lonikar, M.; Venkatesh, K.; Roe,
R. M. Inhibition of insect juvenile hormone esterase by R,â-
unsaturated and R-acetylenic trifluoromethyl ketones. Pestic.
Biochem. Physiol. 1989, 35, 291-299.
(63) Shiotsuki, T.; Huang, T. L.; Hammock, B. D. Affinity purification
of mouse liver carboxylesterases with trifluoromethyl ketones
as ligands. J . Pestic. Sci. 1994, 19, 321-324.
(64) Leo, A. J . Calculating log Poct from structures. Chem. Rev. 1993,
93, 1281-1306.
(65) Thomas, T. C.; Sze´ka´cs, A.; Rojas, S.; Hammock, B. D.; Wilson,
B. W.; et al. Characterization of neuropathy target esterase using
trifluoromethyl ketones. Biochem. Pharmacol. 1987, 40, 2587-
2596.
(66) Morgan, R. S.; McAdon, J . M. Predictor for sulfur-aromatic
interactions in globular proteins. Int. J . Pept. Protein Res. 1980,
15, 177-180.
(67) Bencharit, S.; Morton, C. L.; Howard-Williams, E. L.; Danks,
M. K.; Potter, P. M.; et al. Structural insights into CPT-11
activation by mammalian carboxylesterases. Nat. Struct. Biol.
2002, 9, 337-342.
(68) Thomas, B. A.; Church, W. B.; Lane, T. R.; Hammock, B. D.
Homology model of juvenile hormone esterase from the crop pest,
Heliothis virescens. Proteins 1999, 34, 184-196.
(43) Linderman, R. J .; Leazer, J .; Venkatesh, K.; Roe, R. M. The
inhibition of insect juvenile hormone esterase by trifluorometh-
ylketones: steric parameters at the active site. Pestic. Biochem.
Physiol. 1987, 29, 266-277.
(44) Roe, R. M.; Anspaugh, D. D.; Venkatesh, K.; Linderman, R. J .;
Graves, D. M. A novel geminal diol as a highly specific and stable
in vivo inhibitor of insect juvenile hormone esterase. Arch. Insect
Biochem. Physiol. 1997, 36, 165-179.
(45) Linderman, R. J .; J amois, E. A. A semi-empirical and ab initio
analysis of fluoroketones as reactive electrophiles. J . Fluorine
Chem. 1991, 53, 79-91.
(46) Linderman, R. J .; Tennyson, S. D.; Schultz, D. A. Comparative
stability of fluoroketone hemi-thio acetals, ketals and hydrates.
Tetrahedron Lett. 1994, 35, 6437-3440.
(47) J ensen, F. Introduction to Computational Chemistry; J ohn Wiley
and Sons: New York, 1999.
(69) Guthrie, J . P. Carbonyl addition reactions: Factors affecting the
hydrate-hemiacetal and hemiacetal equilibrium constants. Can.
J . Chem. 1975, 53, 898-906.
(70) Scott, W. J .; Zuman, P. Hydration-dehydration constants of
R,R,R-trifluoroacetophenone by spectral and electrochemical
methods. J . Chem. Soc., Faraday Trans. 1 1976, 1192-1200.
(71) Abdel-Aal, Y. A. I.; Hammock, B. D. Apparent multiple catalytic
sites involved in the ester hydrolysis of juvenile hormones by
the hemolymph and by an affinity-purified esterase from Mand-
uca sexta J ohannson (Lepidoptera: Sphingidae). Arch. Biochem.
Biophys. 1985, 243, 206-219.
(72) Olmstead, M. M.; Musker, W. K.; Hammock, B. D. Structure of
the hydrate form of a â-thiotrifluoromethyl ketone, a potent
esterase inhibitor. Acta Crystallogr. 1987, C43, 1726-1728.
(48) Becke, A. D. Density-functional thermochemistry. III. The role
of exact exchange. J . Chem. Phys. 1993, 98, 5648-5652.